Migraine and Headache

Latest News

Lasmiditan Increases Odds of Freedom From Migraine Attacks

Lasmiditan is associated with greater odds of achieving pain freedom from migraine attacks compared with placebo.

Fremanezumab Found to Reduce Number of Migraine Days in Patients With Chronic Migraine and Comorbid Depression

A pooled analysis evaluated reductions in migraine and headache days among patients with chronic migraine and comorbid depression in 2 placebo-controlled, phase 3 trials of fremanezumab.

Amygdala Connectivity May Predict CBT Efficacy for Adolescent Migraine

Connectivity between the amygdala and specific brain regions may predict headache reduction after cognitive behavioral therapy for adolescent migraine.

About 20 Percent of Women Avoid Pregnancy Due to Migraine

Migraine has a considerable impact on women’s pregnancy plans, with about 20 percent avoiding pregnancy due to migraine.

Effects of Migraine on Disability and Neurological Function in MS

Among patients with multiple sclerosis, a history of migraine may not be associated with worse disability or neurological function.

Contextual Effects Have Role in Benefits of CGRP Antibodies for Migraine

While calcitonin gene related peptide antibodies are effective for episodic and chronic migraine, most of its benefits are from contextual effects.

About One in Three Multiple Sclerosis Patients Have Migraine

Pooled prevalence of migraine was 31 percent in MS patients, with significant variance internationally.

Occipital Headaches More Frequent Among Those With Vestibular Migraine

Patients with vestibular migraine are more likely to have occipital headaches than those without vestibular symptoms.

Occipital Headaches More Common in Patients With vs Without Vestibular Migraine

Compared to patients with migraine without vestibular symptoms, those with vestibular migraine are more likely to experience occipital headaches.

Heterogeneous Headache Characteristics Associated With COVID-19

The heterogeneous expression of headache associated with COVID-19 indicates various underlying pathophysiological mechanisms.